drug metabolism
DESCRIPTION
Detailed information about drug metabolismTRANSCRIPT
![Page 1: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/1.jpg)
1
Presenter :- Dr Swaroop H S
Moderator:- Dr Ananya Chakraborty
Drug Metabolism
Dr Swaroop HS copyighted
![Page 2: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/2.jpg)
2
• Introduction
• History
• Phases of Metabolism
• Phase I Metabolism
• Cytochrome P family
• Phase II Metabolism
• First Pass Metabolism
• Ante drug
• Microsomal Enzyme Induction
• Role of Metabolism in Drug Discovery
Outline
Dr Swaroop HS copyighted
![Page 3: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/3.jpg)
3
• Biotransformation: Chemical alteration of the drug in body that converts nonpolar or lipid soluble compounds to polar or lipid insoluble compounds
• Consequences of biotransformation
• Active drug Inactive metabolite : Pentobarbitone, Morphine, Chloramphenicol
• Active drug Active metabolite: Phenacetin
• Inactive drug active metabolite: Levodopa
Introduction
Dr Swaroop HS copyighted
![Page 4: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/4.jpg)
4
• Inactive drug is converted to active metabolite
• Coined by Albert in 1958
• Advantages:• Increased absorption
• Elimination of an unpleasant taste
• Decreased toxicity
• Decreased metabolic inactivation
• Increased chemical stability
• Prolonged or shortened action
Prodrugs
Dr Swaroop HS copyighted
![Page 5: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/5.jpg)
5
• Welsh biochemist
• Metabolism of sulfonamides, benzene, aniline, acetanilide, phenacetin, thalidomide and stilbesterol
• Metabolism of TNT (Trinitrotoluene) with regard to toxicity in munitions (1942)
History
Richard Tecwyn Williams
1909 - 1979
Dr Swaroop HS copyighted
![Page 6: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/6.jpg)
6
• Phase I• Functionalization reactions
• Converts the parent drug to a more polar metabolite by introducing or unmasking a functional group (-OH, -NH2, -SH).
• Phase II • Conjugation reactions
• Subsequent reaction in which a covalent linkage is formed between a functional group on the parent compound or Phase I metabolite and an endogenous substrate such as glucuronic acid, sulfate, acetate, or an amino acid
Phases of Metabolism
Dr Swaroop HS copyighted
![Page 7: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/7.jpg)
Conjugation
Glucuronic acid
Sulfate, Glycine and other AA
Glutathione or mercapturic acid
Acetylation, Methylation
Reduction
Aldehydes and ketones
Nitro and azo
Miscellaneous
Oxidation
Aromatic moieties, Olefins
Benzylic & allylic C atoms
and a-C of C=O and C=N
At aliphatic and alicyclic C
C-Heteroatom system C-N (N-dealkylation, N-oxide
formation, N-hydroxylation)
C-O (O-dealkylation)
S-dealkylation
S-oxidation, desulfuration
Oxidation of alcohols and
aldehydes, Miscellaneous
Phase II -
ConjugationPhase I -
Functionalization
Drug
Metabolism
Hydrolytic Reactions
Esters, amides, epoxides and
arene oxides by epoxide hydrase
Phases of Metabolism
7Dr Swaroop HS copyighted
![Page 8: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/8.jpg)
Hepatic microsomal enzymes
(oxidation, conjugation)
Extrahepatic microsomal enzymes
(oxidation, conjugation)
Hepatic non-microsomal enzymes
(acetylation, sulfation,GSH,
alcohol/aldehyde dehydrogenase,
hydrolysis, ox/red)
Sites of Drug Metabolism
8Dr Swaroop HS copyighted
![Page 9: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/9.jpg)
9
Oxidation
• Addition of oxygen/ negatively charged radical or removal of hydrogen/ positvely charged radical.
• Reactions are carried out by group of mono-oxygenases in the liver.
• Fianl step: Involves cytochrome P-450 haemoprotein, NADPH, cytochrome P-450 reductase and O2
Phase I / Non Synthetic Reactions
Dr Swaroop HS copyighted
![Page 10: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/10.jpg)
10
• Monooxygenase enzyme family
• Major catalyst: Drug and endogenous compound oxidations in liver, kidney, G.I. tract, skin and lungs
• Oxidative reactions require: CYP heme protein, the reductase, NADPH, phosphatidylcholine and molecular oxygen
• Location: smooth endoplasmic reticulum in close association with NADPH-CYP reductasein 10/1 ratio
• The reductase serves as the electron source for the oxidative reaction cycle
Cytochrome P450 enzymes
Dr Swaroop HS copyighted
![Page 11: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/11.jpg)
CO
huCYP-Fe+2
Drug
CO
O2
e-
e-
2H+
H2O
DrugCYPR-Ase
NADPH
NADP+
OHDrug
CYP Fe+3
PC Drug
CYP Fe+2
Drug
CYP Fe+2
Drug
O2
CYP Fe+3
OHDrug
11
Electron flow in Cytochromes
Dr Swaroop HS copyighted
![Page 12: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/12.jpg)
12
• Multiple CYP gene families have been identified in humans, and the categoriezed based on protein sequence homology
• Most of the drug metabolizing enzymes are in CYP 1, 2, & 3 families .
• Frequently, two or more enzymes can catalyze the same type of oxidation, indicating redundant and broad substrate specificity.
• CYP3A4 is very common to the metabolism of many drugs; its presence in the GI tract is responsible for poor oral availabilty of many drugs
Cytochrome P family
Dr Swaroop HS copyighted
![Page 13: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/13.jpg)
13
• Families: CYP plus arabic numeral (>40% homology of amino acid sequence, eg. CYP1)
• Subfamily: 40-55% homology of amino acid sequence; eg. CYP1A
• Subfamily: Additional arabic numeral when more than 1 subfamily has been identified; eg. CYP1A2
• Italics: Indicate gene (CYP1A2); regular font for enzyme
Cytochrome families Continued….
Dr Swaroop HS copyighted
![Page 14: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/14.jpg)
14
OTHER
36%
CYP2D6
2%
CYP2E1
7%
CYP 2C
17%
CYP 1A2
12%
CYP 3A4-5
26%
Role of CYP Enzymes in Hepatic
Drug Metabolism
CYP 1A2
14%
CYP 2C9
14%
CYP 2C19
11%
CYP2D6
23%
CYP2E1
5%CYP 3A4-5
33%
Relative Hepatic Content
of CYP enzymes
Percentage of Drugs
Metabolized by CYP Enzymes
Dr Swaroop HS copyighted
![Page 15: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/15.jpg)
Cytochromes: Metabolism of Drugs
CYP
Enzyme
Examples of substrates
1A1 Caffeine, Testosterone, R-Warfarin
1A2 Acetaminophen, Caffeine, Phenacetin, R-Warfarin
2A6 17-Estradiol, Testosterone
2B6 Cyclophosphamide, Erythromycin, Testosterone
2C-family Acetaminophen, Tolbutamide (2C9); Hexobarbital, S-
Warfarin (2C9,19); Phenytoin, Testosterone, R- Warfarin,
Zidovudine (2C8,9,19);
2E1 Acetaminophen, Caffeine, Chlorzoxazone, Halothane
2D6 Acetaminophen, Codeine, Debrisoquine
3A4 Acetaminophen, Caffeine, Carbamazepine, Codeine,
Cortisol, Erythromycin, Cyclophosphamide, S- and R-
Warfarin, Phenytoin, Testosterone, Halothane,
Zidovudine
15Adapted from: S. Rendic Drug Metab Rev 34: 83-448, 2002
Dr Swaroop HS copyighted
![Page 16: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/16.jpg)
16
• Monoamine Oxidase (MAO), Diamine Oxidase (DAO)
• MAO (mitochondrial) oxidatively deaminates endogenous substrates including neurotransmitters
• Dopamine, serotonin, norepinephrine, epinephrine
• Alcohol & Aldehyde Dehydrogenase
• Non-specific enzymes found in soluble fraction of liver
• Ethanol metabolism
• Flavin Monooxygenases• Require molecular oxygen, NADPH, flavin adenosine dinucleotide
(FAD)
Non-CYP Drug Oxidations
Dr Swaroop HS copyighted
![Page 17: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/17.jpg)
17
• Converse of oxidation
• Drugs primarily reduced are chloralhydrate, chloramphenicol, halothane.
Reduction
Dr Swaroop HS copyighted
![Page 18: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/18.jpg)
18
• Cleavage of drug molecule by taking up a molecule of water.
• Sites: Liver, intestines, plasma and other tissues
• Examples: Choline esters, Procaine, Isoniazid, pethidine, oxytocin.
Hydrolysis
Dr Swaroop HS copyighted
![Page 19: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/19.jpg)
19
• Cyclization
• Formation of ring structure from a straight chain compound
• E.g. Proguanil
• Decyclization
• Opening up of ring structure of the cyclic drug molecule
• E.g. Barbiturates, Phenytoin.
Cyclization and Decyclization
Dr Swaroop HS copyighted
![Page 20: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/20.jpg)
20
• Conjugation of the drug or its phase I metabolite with an endogenous substrate to form a polar highly ionized organic acid
• Types of phase II reactions• Glcuronide conjugation
• Acetylation, Methylation
• Sulfate conjugation, Glycine conjugation
• Glutathione conjugation
• Ribonucleoside/ nucleotide synthesis
Phase II/ Synthetic reactions
Dr Swaroop HS copyighted
![Page 21: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/21.jpg)
21
• Conjugation to α-d-glucuronic acid
• Quantitatively the most important phase II pathway for drugs and endogenous compounds
• Products are often excreted in the bile
• Requires enzyme UDP-glucuronosyltransferase(UGT)
• Compounds with a hydroxyl or carboxylic acid group are easily conjugated with glucuronic acid which is derived from glucose
Glucuronide Conjugation
Dr Swaroop HS copyighted
![Page 22: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/22.jpg)
22
• Enterohepatic recycling may occur due to gut glucuronidases
• Drug glucuronides excreted in bile can be hydrolysed by bacteria in gut and reabsorbed and undergoes same fate.
• This recycling of the drug prolongs its action e.g.Phenolpthalein, Oral contraceptives
• Examples: Chloramphenicol, aspirin, phenacetin, morphine, metronidazole
Glucuronide Conjugation Continued..
Dr Swaroop HS copyighted
![Page 23: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/23.jpg)
23
• Common reaction for aromatic amines and sulfonamides
• Requires co-factor acetyl-CoA
• Responsible enzyme is N-acetyltransferase
• Important in sulfonamide metabolism because acetyl-sulfonamides are less soluble than the parent compound and may cause renal toxicity due to precipitation in the kidney
• E.g. Sulfonamides, isoniazid, Hydralazine.
Acetylation
Dr Swaroop HS copyighted
![Page 24: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/24.jpg)
24
• Major pathway for phenols but also occurs for alcohols, amines and thiols
• Sulfate conjugates can be hydrolyzed back to the parent compound by various sulfatases
• Sulfoconjugation plays an important role in the hepatotoxicity and carcinogenecity of N-hydroxyarylamides
• Infants and young children have predominating O-sulfate conjugation
• Examples include: a-methyldopa, albuterol, terbutaline, acetaminophen, phenacetin
Sulfate Conjugation
Dr Swaroop HS copyighted
![Page 25: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/25.jpg)
25
Amino Acid Conjugation:• ATP-dependent acid: CoA ligase forms active CoA-
amino acid conjugates which then react with drugs by N-Acetylation:– Usual amino acids involved are:
• Glycine. Glutamine, Ornithine, Arginine
Glutathione Conjugation:
• Glutathione is a protective factor for removal of potentially toxic compounds
• Conjugated compounds can subsequently be attacked by g-glutamyltranspeptidase and a peptidase to yield the cysteine conjugate => product can be further acetylated to N-acetylcysteine conjugateE.g. Paracetamol
Dr Swaroop HS copyighted
![Page 26: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/26.jpg)
26
Inactivation of the drug in the body fluids by spontaneous molecular re arrangement without the agency of any enzyme
e.g. Atracurium.
Hofmann elimination
Dr Swaroop HS copyighted
![Page 27: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/27.jpg)
27
• Metabolism of a drug during its passage from the site of absorption into the systemic circulation.
• Extent of first pass metabolism differs in different drugs
Extent of first pass metabolism of important drugs
First pass Metabolism
Low Intermediate High – not
given orally
High oral dose
Phenobarbitone Aspirin Isoprenaline propranolol
Phenylbutazone Quinidine Lignocaine Alprenolol
Tolbutamide Desipramine Hydrocortisone Verapamil
Pindolol Nortriptyline Testosterone Salbutamol
Dr Swaroop HS copyighted
![Page 28: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/28.jpg)
28
• Oral dose is considerably higher then sublingual or parenteral dose
• Marked individual variation in the oral dose due to differences in the extent of first pass metabolism
• Oral bioavailability is apparently increased in patients with severe liver disease
• Oral bioavailability of a drug is increased if another drug competing with it.
E.G. Chloropromazine and Propranolol
Attributes of drugs with high
first pass metabolism
Dr Swaroop HS copyighted
![Page 29: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/29.jpg)
29
Ante DrugI stopped taking medicineas I prefer original disease
to side effects!!
Because,Vioxx’ll treat pain but who’ll treat
vioxx??
Dr Swaroop HS copyighted
![Page 30: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/30.jpg)
30
An active synthetic drug which is inactivated by a metabolic
process upon entry into the systemic circulation.
Therefore, a true antedrug acts only locally.
True Antedrug
Partial Antedrug
Inactive Metabolite
Less active metabolite
Lee HJ and Soliman MRI (1982). Science, 215, 989.
What is Antedrug?
Dr Swaroop HS copyighted
![Page 31: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/31.jpg)
31
• Localization of the drug effects
• Elimination of toxic metabolites, increasingthe therapeutic index
• Avoidance of pharmacologically activemetabolites that can lead to long-term effects
• Elimination of drug interactions resultingfrom metabolite inhibition of enzymes
• Simplification of PK problems caused bymultiple active species
Advantages of Antedrug
Dr Swaroop HS copyighted
![Page 32: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/32.jpg)
32
• Competitively inhibit the metabolism of another drug if it utilizes the same enzyme or co factors.
• A drug may inhibit one isoenzyme while being itself a substrate of another isoenzyme
e.g. quinidine is metabolized by CYP3A4 but inhibits CYP2D6
• Inhibition of drug metabolism occurs in a dose related manner and can precipitate toxicity of the object drug.
• Blood flow limited metabolism
e.g. Propranolol reduces rate of lignocainemetabolism by decreasing hepatic blood flow.
Inhibition of Metabolism
Dr Swaroop HS copyighted
![Page 33: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/33.jpg)
33
oCertain drugs, insecticides and carcinogens increase the synthesis of microsomal enzyme protein.
oDifferent inducers are relatively selective for certain cytochrome P-450 enzyme families e.g.
• Phenobarbitone , rifampin, glucorticoids induce CYP3A isoenzymes
• Isoniazid and chronic alochol consumption induce CYP2E1
oInduction takes 4-14 days to reach its peak and is maintained till the inducing agent is present.
Microsomal Enzyme Induction
Dr Swaroop HS copyighted
![Page 34: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/34.jpg)
34
• Decreased intensity or Increased Intensity of action of drug
• Tolerance- autoinduction
• Precipitation of acute intermittent porphyria
• Interfere with adjustment of dose of another drug
• Interference with chronic toxicity
Possible Uses of Induction:
Congenital non hemolytic anaemia
Cushing’s Syndrome
Consequences of Induction
Dr Swaroop HS copyighted
![Page 35: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/35.jpg)
35
• New born has low g.f.r and tubular transport is immature, so the t1/2 of the drug like streptomycin and penicillin is prolonged
• Hepatic drug metabolising system is inadequate in new borns e.g. chloramphenicol can produce gray baby syndrome
• In elderly the renal function progressively declines
• Reduction of hepatic microsomal activity and liver blood flow
• Incidence of adverse drug reactions is much higher in elderly
Role of Metabolism in pediatric and
elderly
Dr Swaroop HS copyighted
![Page 36: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/36.jpg)
36
• In drug development it is important to have an information on the enzymes responsible for the metabolism of the candidate drug
• Invitro Studies can give information about
• Metabolite stability
• Metabolite profile
• Metabolite Identification
• CYP induction/Inhibition
• Drug/Drug interaction studies
• CYP isoform identification
Role of Metabolism in Drug discovery
Dr Swaroop HS copyighted
![Page 37: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/37.jpg)
37
• Goodman and Gilman, Pharmacological basis of Therapeutics, 12th edition, Laurence L Bruton
• Essential of Medical Pharmacology, K D Tripathi, 5th
Edition, JP publishers, New Delhi.
• Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry 11th ed. Lippincott, Williams & Wilkins ed
• Drug metabolism by S.P. Markey, NIH, accessed on internet on 02-03-2013 from www.cc.nih.gov/.../ppt/drug_metabolism_2006-2007.ppt
• Drug metabolism and pharmacokinetics in drug discovery: a primer for bioanalytic study: chandranigunaratna, current separations, 19:1, 2000
References
Dr Swaroop HS copyighted
![Page 38: Drug metabolism](https://reader033.vdocuments.net/reader033/viewer/2022052508/559ed00f1a28ab9e0b8b468f/html5/thumbnails/38.jpg)
38
Thank You
Dr Swaroop HS copyighted